AbbVie and Coca-Cola are blue-chip stocks that have excellent financials.
These two stocks proved resilient in 2022, rising in value while the markets crashed.
They are both Dividend Kings, with excellent track records for raising their payouts.
If you're a retiree, you may be concerned about how safe it is to invest in the stock market right now. Valuations are high, economic conditions are questionable, and it's getting more difficult to find quality investments to hang on to and that you won't need to worry about.
But in times like these, there are still safe, high-yielding stocks that you can put your money into and collect a dependable dividend from, while having confidence that their yields will remain high. Two of the best dividend stocks you can buy today (and also happen to pay more than double the S&P 500 average of 1.1%) are AbbVie (NYSE: ABBV) and Coca-Cola (NYSE: KO).
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Here's what makes these dividend stocks stand out.
Image source: Getty Images.
Drugmaker AbbVie spun off from Abbott Laboratories in 2013, and it has continued to not only pay but also grow its dividend since then. And if you go back and include the time it was part of Abbott, then it qualifies as a Dividend King, having raised its payout annually for at least 50 consecutive years.
The company doesn't make just modest increases, either. At the start of 2021, it was paying investors $1.30 per share each quarter. Over five years, AbbVie has boosted that dividend by 33%, to $1.73 today. That translates into a yield of 3.2% right now.
AbbVie has experienced some volatility in its earnings (due to acquisitions), which makes its payout ratio at the moment look concerningly high at well over 100%, but this is a much safer dividend stock than that ratio would suggest. In the trailing 12 months, the company's free cash flow has totaled nearly $20 billion -- far higher than the $11.5 billion it paid in dividends over that time frame.
The healthcare stock has a diverse mix of products that make up its strong, consistent numbers. And it has added to its pipeline over the years via acquisitions, setting it up for more potential growth in the years ahead. The stock's low beta value of 0.35 is another great reason to love it for the dividend income, as it isn't likely to show wild swings in value. In 2022, when the S&P 500 crashed by 19%, shares of AbbVie rose by more than 19%.
Overall, AbbVie can be a rock-solid income investment to hang on to for both the short term and the long haul.
A top name that undoubtedly comes to mind if you're considering dividend investing is Coca-Cola. It's also a Dividend King, having raised its annual payout for an impressive 63 straight years. In five years, it has grown its payout by 24%, which is a more modest rate than AbbVie's but still a solid pace that helps retirees offset the effects of inflation. Currently, it yields 2.9%.
This is another low-volatility stock, as Coca-Cola's beta is 0.39. And in 2022, its share price rose by more than 7%, as it also defied the stock market's decline that year, highlighting its resilience to challenging market conditions.
Coca-Cola has been able to raise prices amid inflation and largely weather the economic storm in recent years. While its sales haven't been through the roof, it has been able to steadily increase its top line by 3% in 2024 and 6% the year before that.
This is the type of steady growth that can be counted on for dependable and consistent gains for investors, and leads to more dividend growth in the future. Coca-Cola's payout ratio sits at around 67% today, leaving plenty of room for more rate hikes. This is another stellar investment that can be ideal for risk-averse investors who just want to collect a dividend and not worry about anything else.
Before you buy stock in AbbVie, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $460,340!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,123,789!*
Now, it’s worth noting Stock Advisor’s total average return is 937% — a market-crushing outperformance compared to 194% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of January 22, 2026.
David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie and Abbott Laboratories. The Motley Fool has a disclosure policy.